期刊文献+

非酒精性脂肪性肝病与冠心病的相关性研究 被引量:4

Correlation between Nonalcoholic Fatty Liver Disease and Coronary Heart Disease
下载PDF
导出
摘要 目的研究非酒精性脂肪性肝病(NAFLD)与冠心病(CHD)的相关性,阐明其作为冠心病预测因素的价值,为冠心病的预防和治疗提供资料和依据。方法随机选取疑诊"冠心病"住院的患者101例行冠状动脉造影和肝脏超声检查,确诊冠心病69例(冠心病组),其中合并NAFLD 44例(CHD-NAFLD组),单纯冠心病25例(单纯CHD组);非冠心病患者32例(非冠心病组),其中合并NAFLD 7例(单纯NAFLD组),未合并NAFLD者25例(对照组)。收集患者的基本临床资料并检测血生化指标。结果冠心病患者中NAFLD发生率明显高于非冠心病患者(63.77%和21.87%,P<0.01),合并NAFLD的冠心病患者以多支病变为主(P<0.05),且冠状动脉病变程度较重。Logistic回归分析显示,NAFLD可以独立地增加冠心病的发病风险〔P=0.001,OR=6.014,95%CI(2.104,17.192)〕。结论 NAFLD与冠心病存在明显的独立相关性,且与冠心病的严重程度相关,NAFLD是冠心病独立危险因素,可用其初步评估心血管事件发生的危险程度。 Objective To explore the possible relationship between nonalcoholic fatty liver disease(NAFLD) and coronary heart disease(CHD).Methods A total of 101 randomly selected patients with suspected CHD underwent coronary angiography and abdominal ultrasonography.Among whom 69 cases were confirmed to be with CHD,including 44 cases complicated by NAFLD(CHD-NAFLD group) and 25 cases with simple CHD(simple CHD group);32 cases were excluded the possibilities of CHD,among whom 7 cases were confirmed to be with NAFLD(simple NAFLD group) and another 25 cases without NAFLD fell into control group.The medical history was collected and blood biochemical analyses were performed.Results The prevalence of NAFLD in the CHD group was significantly higher than that in the non-CHD groups(63.77% vs.21.87%,P0.01).Most patients in the CHD-NAFLD group had multi-vessel lesions in the coronary artery(P0.05),and coronary artery lesions tended to be more severe.Logistic regression analysis indicated that NAFLD independently increased the risk of CHD(P=0.001,OR=6.014,95%CI(2.104,17.192)).Conclusion NAFLD is an independent predicator for CHD and is related to the severity of CHD.
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第14期1575-1578,共4页 Chinese General Practice
关键词 非酒精性脂肪性肝病 冠心病 危险因素 Nonalcoholic fatty liver disease Coronary heart disease Risk factor
  • 相关文献

参考文献22

  • 1Farre11 GC, George J, Pauline de la M, et al. Fatty liver disease: NASH and related disorders [ M ]. Oxford: Blackwell Publishing, 2005 : 1 - 22.
  • 2刘哲慧,李冠增,田字彬.青年男性肝酶增高非酒精性脂肪肝患者糖耐量异常的研究[J].中国全科医学,2011,14(6):607-610. 被引量:5
  • 3Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome [ J ]. Lancet, 2005, 365: 1415-1428.
  • 4Adams LA, Angulo P. Recent concepts in non - alcoholic fatty liver disease [J]. Diabet Med, 2005, 22: 1129-1233.
  • 5范慧,张鹏睿,徐援.2型糖尿病合并非酒精性脂肪肝与胰岛素抵抗及心血管病变发生的关系研究[J].中国全科医学,2011,14(2):147-150. 被引量:69
  • 6Neuschwander- Tetri BA. Nonalcoholic steato- hepatitis and the meta- bolic syndrome [J]. Am J Med Sci, 2005, 330:326 -335.
  • 7Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease [ J]. Ann Intern Med, 2005, 143 : 722 -728.
  • 8Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in non -diabetic patients with non -alcoholic fatty liver disease: sites and mechanisms [ J]. Diabetologia, 2005, 48: 634-642.
  • 9Gensini GG. A more meaningful scoring system for determining the se- verity of coronary heart disease [J]. Am J Cardiol, 1983, 51 : 606 - 607.
  • 10非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18(3):163-166. 被引量:1150

二级参考文献26

共引文献1215

同被引文献36

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部